These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2725937)

  • 41. Poor outcome from peritoneovenous shunts for refractory ascites.
    Scholz DG; Nagorney DM; Lindor KD
    Am J Gastroenterol; 1989 May; 84(5):540-3. PubMed ID: 2719011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Palliation of malignant ascites by the Denver peritoneovenous shunt.
    Downing R; Black J; Windsor CW
    Ann R Coll Surg Engl; 1984 Sep; 66(5):340-3. PubMed ID: 6207757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Five cases of disseminated intravascular coagulation after peritoneojugular shunt by Le Veen valve].
    Jobard J; Marcillon M; Guillot F; Maestracci P
    Ann Anesthesiol Fr; 1980; 21(5):531-4. PubMed ID: 6109502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Peritoneo-jugular shunt for intractable ascites in cirrhosis: 88 cases (author's transl)].
    Franco D; Cortesse A; Castro e Sousa F; Bismuth H
    Gastroenterol Clin Biol; 1981 Apr; 5(4):393-402. PubMed ID: 7227747
    [No Abstract]   [Full Text] [Related]  

  • 45. Denver peritoneovenous shunting for malignant or cirrhotic ascites. A prospective consecutive series.
    Söderlund C
    Scand J Gastroenterol; 1986 Dec; 21(10):1161-72. PubMed ID: 3809991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
    Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Saphenous--peritoneal shunt in refractory ascites: a neglected technique.
    Thapa PB; Rungta A; Joshi MR; Singh DR; Sharma SK
    JNMA J Nepal Med Assoc; 2006; 45(162):258-61. PubMed ID: 17189972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of hemorrhagic syndrome caused by peritoneovenous shunt with a flow regulation device].
    Violi V; Montanari M; Roncoroni L
    G Chir; 1990; 11(7-8):413-5. PubMed ID: 2282274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The LeVeen peritoneovenous shunt--an alternative in therapy-resistant ascites].
    Pahlig H; Abri O; Wolff H; Greiner H; Buchali K; Hollerbuhl H
    Zentralbl Chir; 1985; 110(13):835-41. PubMed ID: 3875951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experience with LeVeen peritoneal-venous shunt in the treatment of intractable cirrhotic ascites].
    Chen YR; Chen MC
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):431-3. PubMed ID: 6641389
    [No Abstract]   [Full Text] [Related]  

  • 51. Role of surgical therapy in management of intractable ascites.
    Elcheroth J; Vons C; Franco D
    World J Surg; 1994; 18(2):240-5. PubMed ID: 8042329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic results of Denver percutaneous peritoneovenous shunt in cancer patients with malignant ascites.
    Tamagawa H; Aoyama T; Inoue H; Fujikawa H; Sawazaki S; Numata M; Sato T; Oshima T; Yukawa N; Morimoto M; Ueno M; Rino Y; Masuda M
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S95-S98. PubMed ID: 33380660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of the Leveen shunt in the treatment of clinically intractable ascites].
    D'Albuquerque LA; de Oliveira e Silva A; Genzini T; de Miranda MP; Arab-Fadul R; Gama-Rodrigues JJ
    Arq Gastroenterol; 1988; 25(3):138-44. PubMed ID: 3255281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.
    Piccirillo M; Rinaldi L; Leongito M; Amore A; Crispo A; Granata V; Aprea P; Izzo F
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3668-3673. PubMed ID: 28925475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current status of the peritoneovenous shunt for the management of intractable ascites.
    Fry PD; Hallgren R; Robertson ME
    Can J Surg; 1979 Nov; 22(6):557-9. PubMed ID: 497929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Surgical treatment of refractory ascites with peritoneovenous shunt].
    Massari R; Fulgente R; Marinelli S; Romessis M
    Chir Ital; 1995; 47(1):57-0. PubMed ID: 8706187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of preoperative tests in the surgical treatment of ascites with the implant of Le Veen shunts in cirrhotics.
    D'Albuquerque LA; de Oliveira e Silva A; Genzini T; de Miranda MP; Roldan-Molina F
    Arq Gastroenterol; 1991; 28(4):124-31. PubMed ID: 1843248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chylous ascites: resolution after Denver peritoneovenous shunt.
    Turner WW
    South Med J; 1983 Apr; 76(4):539. PubMed ID: 6601302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Correlation between long survival and shunt patency in patients treated surgically for refractory ascites].
    Vincze K; Herke L; Pécsi B
    Orv Hetil; 1994 Mar; 135(11):569-72. PubMed ID: 8159409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Denver type for peritoneovenous shunting of malignant ascites.
    Roussel JG; Kroon BB; Hart GA
    Surg Gynecol Obstet; 1986 Mar; 162(3):235-40. PubMed ID: 2420017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.